THE BUYER & PROBLEM
GP practices with a coding queue.
Coding teams must preserve diagnoses, medicine changes, results and follow-up from each letter. Practice managers and clinical leads are the proposed pilot decision-makers.
Actively raising · pre-seed
A clinician-built workspace.
A clearer coding decision.
Working MVP for UK primary care. Raising £250k to support independent validation, practice pilots and the path to paid adoption.
Proposed pre-seed round£250k£50k strategic first close planned
Current stageWorking MVPReady for design-partner pilots
First customersUK GP practicesClinical leads and coding teams
FOUNDER & CEO
Dr Shamim Safkat Khan
MBBS · MSc Psychology of Mental Health
Lead Clinical Coder across seven GP sites, with around three years in coding and seven years in software development. Trained or supported 15+ staff and built the product’s workflow and architecture.
Watch the three-minute investor brief
THE OPPORTUNITY
Start with correspondence.
Earn the next workflow.
THE PRODUCT APPROACH
Evidence stays beside the decision.
Source highlights, concept alternatives, context controls and review alerts in one workspace, designed around the clinician’s coding decision.
THE ROUTE TO REVENUE
Pilot, measure, then convert.
Founder-led conversations → a scoped 12-week evaluation → measured quality and time → a paid-practice decision. Target 3–5 pilots before wider adoption.
PROPOSED SUBSCRIPTION
6.5p per registered patient / month
£650 monthly for an illustrative 10,000-patient practice. Pricing and willingness to pay remain pilot questions.
PROPOSED USAGE OPTION
15.99p per letter · software only
An alternative to subscription. Integration costs, human review and cost to serve must be evaluated separately.
INITIAL COMMERCIAL TARGET
10–25 practices
At the illustrative practice size and subscription above: £78k–£195k annual recurring revenue. A scenario, not contracted revenue or a forecast.
The initial market is UK general practice. Referrals, recalls and broader results automation are future expansion plans; their potential revenue is excluded from this coding-only scenario.
EARLY EVIDENCE / OCTOBER 2026
Two early checks.
Different questions.
Early evidence informs the next stage. Independent validation remains a pilot objective.
October 2026
SYNTHETIC DEVELOPMENT SET
106/107
Expected SNOMED concepts correct
23 synthetic letters · recorded 9 October 2026. Also measured: 153/153 expected facts found and 130/132 assertions correct.
Development cases reused during tuning, with an in-house answer key. Recall is not overall accuracy. One incorrect concept and two incorrect assertions remained; expected uncoded handling was 31/46.
INITIAL REAL-LETTER CHECK
141/147
Marked suggestions judged right
13 real letters; 147 of 150 items marked by Dr Shamim Safkat Khan on 12 October 2026, from a 3 October pipeline run.
The marker is also the founder. Five wrong-code suggestions and one item that should not be filed remained. This internal check is not independent validation or a measure of missed facts.
What’s built, and what remains before deployment +
BUILT
A working review workflow
- Document ingestion and clinical extraction
- Evidence-linked suggestions and review flags
- Clinician decisions and reviewed exports
- EMIS filing agent tested in simulation
NEXT TO ESTABLISH
The evidence for deployment
- Independent clinical validation
- Time saved and cost to serve in a practice
- A live EMIS test and approved integration route
- Clinical safety, NHS assurance and security review
THE £250K PRE-SEED PLAN
Fund the next
measurable milestones.
The objective is independently evaluated pilots and a credible route to deployment and paid adoption.
£50k strategic first close
Proposed priority: independent review, clinical safety input and preparation for the first scoped pilot.
£200k subsequent funding
Proposed priority: engineering capacity, further practice pilots, assurance work and commercial validation.
Staging priorities are a proposed delivery sequence, not separate committed budgets. Terms and milestones remain subject to agreement. SEIS eligibility and advance assurance are unconfirmed.
Discuss the round~17 monthsLean plan
~13 monthsWith a pilot lead
Planning runway at the deck’s average burn, without assuming revenue. The lean plan includes a £30k founder salary, a £50k developer and 20 clinical-safety-officer days.
First-year lean budget · approximately £177.1k +
- Founder and developer, including employer costs
- £92.5k
- Clinical safety officer
- £19.0k
- Compliance and security
- £14.5k
- Integration provider (assumed)
- £14.0k
- Clinical marking, legal, cloud, desks and pilots
- £21.0k
- 10% contingency
- £16.1k
Rounded planning estimates from the send-ahead deck, not quotes. Integration-provider fees remain assumptions. The full plan adds a £45k pilot lead from month four and 30 safety-officer days; first-year spend is approximately £231k.
01
Evaluate in practice
Run the first scoped 12-week pilot, then target 3–5 pilots. Measure time, acceptance, missed facts and cost.
02
Build deployment evidence
Independent clinician marking, clinical safety capacity, security review and an approved integration route. Live EMIS filing remains untested.
03
Test paid adoption
Validate pricing and support needs. Target 10–25 paying practices once pilot results support progression.
INVESTOR CONVERSATIONS
Meet the founder.
Explore the round.
Request the current deck, ask about the funding plan, or arrange a walkthrough of the working MVP.
Prefer email? invest@snomedcoder.com
This form prepares an email for you to send to the founder. Your entries stay in this browser until you choose to send the email. This website does not subscribe you to marketing or store a contact database. Please do not include patient information.